Melanoma / Skin

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(BMS) CA045001A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic MelanomaTozer, Dr RichardOpen to recruitmentNCT03635983
(CCTG) ME.13/STOP-GAPA Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)Healy, Dr BrianOpen to recruitmentNCT02821013
(CCTG) ME.15 / MelMarT-IIMelanoma Margins Trial: A Phase III, Multi-centre, Multi-national Randomized Control Trial Investigating 1cm vs 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MelMarT-II)Francescutti, Dr ValerieOpen to recruitmentNCT03860883
(Merck) MK-3475-630A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Pembrolizumab versus Placebo as Adjuvant Therapy Following Surgery and Radiation of High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC)Tozer, Dr RichardOpen to recruitmentNCT03833167
Download PDF